Nila Hemed
Overview
Explore the profile of Nila Hemed including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
92
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sigawi T, Gelman R, Maimon O, Yossef A, Hemed N, Agus S, et al.
Front Oncol
. 2024 Aug;
14:1426426.
PMID: 39139285
Introduction: The main obstacle in treating cancer patients is drug resistance. Lenvatinib treatment poses challenges due to loss of response and the common dose-limiting adverse events (AEs). The Constrained-disorder-principle (CDP)-based...
2.
Lalazar G, Mizrahi M, Turgeman I, Adar T, Ben Yaacov A, Shabat Y, et al.
J Clin Immunol
. 2015 Apr;
35(4):399-407.
PMID: 25876706
Unlabelled: Oral administration of anti-CD3 antibodies induced regulatory T cells (Tregs) alleviating the insulin resistance and liver damage in animal models. Objective: To determine the safety and biological effects of...
3.
Ilan Y, Zigmond E, Lalazar G, Dembinsky A, Ben Yaacov A, Hemed N, et al.
J Clin Immunol
. 2009 Sep;
30(1):167-77.
PMID: 19756989
Introduction: Parenteral OKT3 is used to treat transplant rejection and a humanized anti-CD3 Mab has shown positive clinical effects in new onset diabetes. Oral administration of anti-CD3 has not been...
4.
Gabbay E, Zigmond E, Pappo O, Hemed N, Rowe M, Zabrecky G, et al.
World J Gastroenterol
. 2007 Sep;
13(40):5317-23.
PMID: 17879400
Aim: To assess the safety and efficacy of antioxidant therapy for patients with chronic hepatitis C virus (HCV) infection. Methods: One hundred chronic HCV infection patients failed in interferon treatment...